These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 23845847

  • 21. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP.
    Blood; 2000 Feb 01; 95(3):837-45. PubMed ID: 10648394
    [Abstract] [Full Text] [Related]

  • 22. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 23. Hematological changes as prognostic indicators of survival: similarities between Gottingen minipigs, humans, and other large animal models.
    Moroni M, Lombardini E, Salber R, Kazemzedeh M, Nagy V, Olsen C, Whitnall MH.
    PLoS One; 2011 Oct 01; 6(9):e25210. PubMed ID: 21969873
    [Abstract] [Full Text] [Related]

  • 24. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
    Singh VK, Kulkarni S, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Hendrickson H, Gulani J, Ghosh SP, Kumar KS, Hauer-Jensen M.
    Radiat Res; 2016 Mar 01; 185(3):285-98. PubMed ID: 26930378
    [Abstract] [Full Text] [Related]

  • 25. Association of Hematological Nadirs and Survival in a Nonhuman Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome.
    Gluzman-Poltorak Z, Vainstein V, Basile LA.
    Radiat Res; 2015 Aug 01; 184(2):226-30. PubMed ID: 26207689
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Filgrastim for the treatment of hematopoietic acute radiation syndrome.
    Farese AM, MacVittie TJ.
    Drugs Today (Barc); 2015 Sep 01; 51(9):537-48. PubMed ID: 26488033
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hematopoietic radiation syndrome in the Gottingen minipig.
    Moroni M, Coolbaugh TV, Lombardini E, Mitchell JM, Moccia KD, Shelton LJ, Nagy V, Whitnall MH.
    Radiat Res; 2011 Jul 01; 176(1):89-101. PubMed ID: 21520996
    [Abstract] [Full Text] [Related]

  • 30. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ, Bennett AW, Farese AM, Taylor-Howell C, Smith CP, Gibbs AM, Prado K, Jackson W.
    Health Phys; 2015 Nov 01; 109(5):427-39. PubMed ID: 26425903
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors.
    Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R, Finke J.
    Bone Marrow Transplant; 1999 May 01; 23(10):983-90. PubMed ID: 10373062
    [Abstract] [Full Text] [Related]

  • 33. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 34. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K, Rzepecki P, Oborska S, Wasko-Grabowska A.
    Transplant Proc; 2011 Oct 01; 43(8):3114-5. PubMed ID: 21996240
    [Abstract] [Full Text] [Related]

  • 35. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.
    Exp Hematol; 2003 Jan 01; 31(1):89-97. PubMed ID: 12543111
    [Abstract] [Full Text] [Related]

  • 36. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
    Lee CL, Lento WE, Castle KD, Chao NJ, Kirsch DG.
    Radiat Res; 2014 May 01; 181(5):445-51. PubMed ID: 24720754
    [Abstract] [Full Text] [Related]

  • 37. Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model.
    Bertho JM, Frick J, Prat M, Demarquay C, Dudoignon N, Trompier F, Gorin NC, Thierry D, Gourmelon P.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):911-20. PubMed ID: 15913916
    [Abstract] [Full Text] [Related]

  • 38. Acceleration of hemopoietic recovery in dogs after extended-field partial-body irradiation by treatment with colony-stimulating factors: rhG-CSF and rhGM-CSF.
    Nothdurft W, Kreja L, Selig C.
    Int J Radiat Oncol Biol Phys; 1997 Mar 15; 37(5):1145-54. PubMed ID: 9169825
    [Abstract] [Full Text] [Related]

  • 39. Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome.
    Yamaguchi M, Suzuki M, Funaba M, Chiba A, Kashiwakura I.
    Stem Cell Res Ther; 2020 Aug 03; 11(1):339. PubMed ID: 32746943
    [Abstract] [Full Text] [Related]

  • 40. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK, Hauer-Jensen M.
    Int J Mol Sci; 2016 May 03; 17(5):. PubMed ID: 27153057
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.